Wednesday, February 17, 2016

British Journal of Cancer - Table of Contents alert Volume 114 Issue 4

If you are unable to see the message below, click here to view.
British Journal of Cancer

TABLE OF CONTENTS

Volume 114, Issue 4 (357-484)
Published online 16 February 2016

In this issue
Minireviews
Clinical Studies
Translational Therapeutics
Molecular Diagnostics
Genetics and Genomics

Also new today
Advance online publication
Digital Edition
Sign up for e-alerts Sign up for e-alerts
Recommend to your library
Web feed
Subscribe

Minireviews

Top

Oncolytic viruses: finally delivering

Leonard W Seymour and Kerry D Fisher

Br J Cancer 2016 114: 357-361; advance online publication, January 14, 2016; 10.1038/bjc.2015.481

Abstract | Full Text

Antibody-drug conjugates—an emerging class of cancer treatment

Nikolaos Diamantis and Udai Banerji

Br J Cancer 2016 114: 362-367; advance online publication, January 7, 2016; 10.1038/bjc.2015.435

Abstract | Full Text

Clinical Studies

Top

Tumour budding with and without admixed inflammation: two different sides of the same coin?

Nicole Max, Lars Harbaum, Marion J Pollheimer, Richard A Lindtner, Peter Kornprat and Cord Langner

Br J Cancer 2016 114: 368-371; advance online publication, January 14, 2016; 10.1038/bjc.2015.454

Abstract | Full Text

Phase II study of necitumumab plus modified FOLFOX6 as first-line treatment in patients with locally advanced or metastatic colorectal cancer

E Elez, A Hendlisz, T Delaunoit, J Sastre, A Cervantes, R Varea, G Chao, J Wallin and J Tabernero

Br J Cancer 2016 114: 372-380; advance online publication, January 14, 2016; 10.1038/bjc.2015.480

Abstract | Full Text

Chemotherapy vs supportive care alone for relapsed gastric, gastroesophageal junction, and oesophageal adenocarcinoma: a meta-analysis of patient-level data

Tobias Janowitz, Peter Thuss-Patience, Andrea Marshall, Jung Hun Kang, Claire Connell, Natalie Cook, Janet Dunn, Se Hoon Park and Hugo Ford

Br J Cancer 2016 114: 381-387; 10.1038/bjc.2015.452

Abstract | Full Text

Relationship between paediatric CT scans and subsequent risk of leukaemia and brain tumours: assessment of the impact of underlying conditions

Amy Berrington de Gonzalez, Jane A Salotti, Kieran McHugh, Mark P Little, Richard W Harbron, Choonsik Lee, Estelle Ntowe, Melissa Z Braganza, Louise Parker, Preetha Rajaraman, Charles Stiller, Douglas R Stewart, Alan W Craft and Mark S Pearce

Br J Cancer 2016 114: 388-394; 10.1038/bjc.2015.415

Abstract | Full Text

Validity of the online PREDICT tool in older patients with breast cancer: a population-based study

N A de Glas, E Bastiaannet, C C Engels, A J M de Craen, H Putter, C J H van de Velde, A Hurria, G J Liefers and J E A Portielje

Br J Cancer 2016 114: 395-400; advance online publication, January 19, 2016; 10.1038/bjc.2015.466

Abstract | Full Text

Effects of a lifestyle intervention on endothelial function in men on long-term androgen deprivation therapy for prostate cancer

Stephen E Gilbert, Garry A Tew, Caroline Fairhurst, Liam Bourke, John M Saxton, Edward M Winter and Derek J Rosario

Br J Cancer 2016 114: 401-408; advance online publication, January 14, 2016; 10.1038/bjc.2015.479

Abstract | Full Text

Translational Therapeutics

Top

Human papillomavirus vaccination induces neutralising antibodies in oral mucosal fluids

A Handisurya, C Schellenbacher, A Haitel, T Senger and R Kirnbauer

Br J Cancer 2016 114: 409-416; advance online publication, February 11, 2016; 10.1038/bjc.2015.462

Abstract | Full Text

Cell line and patient-derived xenograft models reveal elevated CDCP1 as a target in high-grade serous ovarian cancer

Brittney S Harrington, Yaowu He, Claire M Davies, Sarah J Wallace, Mark N Adams, Elizabeth A Beaven, Deborah K Roche, Catherine Kennedy, Naven P Chetty, Alexander J Crandon, Christopher Flatley, Niara B Oliveira, Catherine M Shannon, Anna deFazio, Anna V Tinker, C Blake Gilks, Brian Gabrielli, Donal J Brennan, Jermaine I Coward, Jane E Armes, Lewis C Perrin and John D Hooper

Br J Cancer 2016 114: 417-426; advance online publication, February 4, 2016; 10.1038/bjc.2015.471

Abstract | Full Text

Survivin and XIAP: two valuable biomarkers in medullary thyroid carcinoma

Thomas A Werner, Yasemin Tamkan-Ölcek, Levent Dizdar, Jasmin C Riemer, Achim Wolf, Kenko Cupisti, Pablo E Verde, Wolfram T Knoefel and Andreas Krieg

Br J Cancer 2016 114: 427-434; advance online publication, February 4, 2016; 10.1038/bjc.2016.5

Abstract | Full Text

Non-thermal atmospheric plasma induces ROS-independent cell death in U373MG glioma cells and augments the cytotoxicity of temozolomide

Gillian E Conway, Alan Casey, Vladimir Milosavljevic, Yupeng Liu, Orla Howe, Patrick J Cullen and James F Curtin

Br J Cancer 2016 114: 435-443; advance online publication, February 4, 2016; 10.1038/bjc.2016.12

Abstract | Full Text

Molecular Diagnostics

Top

Phosphorylation of eIF4E serine 209 is associated with tumour progression and reduced survival in malignant melanoma

Julia H Carter, James A Deddens, Nelson Reed Spaulding IV, Denise Lucas, Bruce M Colligan, Thomas Grant Lewis, Elyse Hawkins, Jordan Jones, Jackson O Pemberton, Larry E Douglass and Jeremy R Graff

Br J Cancer 2016 114: 444-453; advance online publication, February 4, 2016; 10.1038/bjc.2015.450

Abstract | Full Text

A urinary microRNA signature can predict the presence of bladder urothelial carcinoma in patients undergoing surveillance

Nikhil Sapre, Geoff Macintyre, Michael Clarkson, Haroon Naeem, Marek Cmero, Adam Kowalczyk, Paul D Anderson, Anthony J Costello, Niall M Corcoran and Christopher M Hovens

Br J Cancer 2016 114: 454-462; advance online publication, January 26, 2016; 10.1038/bjc.2015.472

Abstract | Full Text

High level of interleukin-10 in serum predicts poor prognosis in multiple myeloma

Hua Wang, Liang Wang, Pei-dong Chi, Wei-da Wang, Xiao-qin Chen, Qi-rong Geng, Zhong-jun Xia and Yue Lu

Br J Cancer 2016 114: 463-468; advance online publication, February 4, 2016; 10.1038/bjc.2016.11

Abstract | Full Text

New ARCHITECT plasma pro-gastrin-releasing peptide assay for diagnosing and monitoring small-cell lung cancer

Benjamin Nisman, Hovav Nechushtan, Haim Biran, Nir Peled, Hadas Gantz-Sorotsky, Victoria Doviner, Marina Perelman, Jair Bar, Amir Onn, Beatrice Uziely and Tamar Peretz

Br J Cancer 2016 114: 469-476; advance online publication, January 26, 2016; 10.1038/bjc.2016.7

Abstract | Full Text

Genetics and Genomics

Top

A large microRNA cluster on chromosome 19 is a transcriptional hallmark of WHO type A and AB thymomas

Milan Radovich, Jeffrey P Solzak, Bradley A Hancock, Madison L Conces, Rutuja Atale, Ryan F Porter, Jin Zhu, Jarret Glasscock, Kenneth A Kesler, Sunil S Badve, Bryan P Schneider and Patrick J Loehrer

Br J Cancer 2016 114: 477-484; advance online publication, January 14, 2016; 10.1038/bjc.2015.425

Abstract | Full Text

Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to British Journal of Cancer. In order to do so, please purchase a subscription.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Nature Publishing Group |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA

Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS.

© 2016 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.

nature publishing group
 

No comments: